Presentation pain mgt

7

Transcript of Presentation pain mgt

Page 1: Presentation pain mgt
Page 2: Presentation pain mgt

Values in Rs. Crores MAT SEP'08 MAT SEP'09 MAT SEP'10 MAT SEP'11 CAGR 2008-11)

YoY Growth (2010-11)

Pain/Analgesics Market

2920 3274 3967 4430 15% 12%

Page 3: Presentation pain mgt

Opportunities MAT

SEP'08

MAT

SEP'09 MAT

SEP'10

MAT

SEP'11

CAGR (MAT 2008-

2011)

YoY Growth (MAT 2010-

11)

Grand Total 2920 3274 3967 4430 15% 12%

CALCITRIOL & COMB 166 224 293 358 29% 22%

NSAIDS 151 182 232 300 26% 30%

ACECLOFENAC + PARACETAMOL 91 104 128 152 19% 19%

PARACE.+ACECLOF.+SERRAPE. 43 52 68 87 27% 27%

THIOCOLCHICOSIDE COMB. 2 18 38 51 191.72% 34.65%

ETODOLAC 9 21 25 24 39% -5%

Page 4: Presentation pain mgt

GROUP MAT SEP'08 MAT SEP'09 MAT SEP'10 MAT SEP'11CAGR

( 2008-2011)YoY Gwth (2010-11)

M01A ANTIRHEUMATIC NONSTR. 1554 1670 1939 2036 9% 5%

M01B ANTIRHEU.PROTEOLYTIC ENZ. 77 80 98 102 10% 5%

M01C ANTIRHEUM.STEROID COMB. 0 0 0 0 #NUM! -100%

M02A TOPICAL ANTIRHEUMATICS 222 264 330 398 21% 21%

M03A MUSCLE RELAXANTS 13 12 9 8 -14% -8%

M03B MUSCLE RELAXANTS SYSTEMIC 159 211 294 345 29% 18%

M04A ANTIGOUT PREPARATIONS 26 36 49 78 44% 57%

M05A OTH.FOR MUSCULO.DISORDER 0 0 1 1 33% 21%

M05B ANTI-ARTHRITIC PREP. 114 135 173 219 24% 26%

M05C ANTI-OSTEOPOROSIS PREP. 268 328 417 496 23% 19%

N01A ANAESTHETICS GENERAL 13 16 19 20 17% 4%

N01B ANAESTHETICS LOCAL 31 33 40 50 18% 23%

N02A NARCOTIC PREP. 3 4 5 6 20% 12%

N02B NON-NARCOTICS-ANTIPYER. 439 483 593 671 15% 13%

Grand Total 2920 3274 3967 4430 15% 12%

Page 5: Presentation pain mgt
Page 6: Presentation pain mgt

Pain Therapy Market is valued at 4430 Cr growing at CAGR 14.9%.In the main Groups anti Rheumatic NSAIDs, Topical AntiRheumatics, Anti Osteoporosis Preparations & Anti Arthritic groups are growing above Market growth.

Aceclofenac + Paracetamol, Thiocolchicosides + Combinations ,Etodolac Ademethionine along with Topical Preparations are the molecules growing in the segment substantially.

Aceclofenac + Paracetamol is well accepted due to safety profile. Rxed by alll specialities

Etodolac is Rxed mostly by Physicians & Orthos mostly as AntiArthritic Drug

Thiocolchicosides + Combinations are having Good growth & Market share

Page 7: Presentation pain mgt